MHS
PDLI

M Holdings Securities’s PDL BioPharma, Inc. PDLI Stock Holding History

M Holdings Securities’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-23,376
Closed – – 518
2014
Q3 		$0 Hold
23,376
– – ﹤0.01% 545
2014
Q2 		$226K Sell
23,376
-846
-3% -$7.54K 0.14% 166
2014
Q1 		$201K Buy
+24,222
New +$208K 0.21% 129

Other funds holding PDLI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

M Holdings Securities's PDLI Position: Q4 2014 in Review

M Holdings Securities sold out of PDL BioPharma, Inc. (PDLI) in Q4 2014, closing a stake of 23,376 shares.

M Holdings Securities first reported a position in PDLI in Q1 2014 and held it in 3 quarters. The position peaked at $226K in Q2 2014. 223 funds tracked by Wall St. Rank hold PDLI as of Q4 2014.

  • M Holdings Securities reported no remaining PDL BioPharma, Inc. position as of Q4 2014 after selling out during the quarter.
  • M Holdings Securities sold 23,376 PDL BioPharma, Inc. shares in Q4 2014.
  • M Holdings Securities first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 3 quarters.
  • M Holdings Securities's PDL BioPharma, Inc. position peaked at $226K in Q2 2014.
  • 223 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2014.

Based on M Holdings Securities's 13F filing for Q4 2014, filed 13 Feb 2015.